About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

ID as a Promoter of IH-induced CAVD | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT06200870

ID as a Promoter of IH-induced CAVD

Calcific aortic valve disease (CAVD) is a highly prevalent, disabling and costly disorder with generally poor long-time outcomes once critical stenosis presents with symptoms. Elucidating viable thera...

Lead sponsor: Qilu Hospital of Shandong University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Qilu Hospital of Shandong University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•if performed with both color doppler echocardiography and anemia profile on admission as part of routine checkup.

Exclusion Criteria

•if younger than the age of 18;
•if no anemia profile or doppler echocardiography was measured;
•if anemia profile or doppler echocardiography was analyzed in external laboratories;
•if had a history of rheumatic heart disease, infective endocarditis or any other congenital disorders that may implicate aortic valve structures, such as bicuspid aortic valve morphology, Marfan syndrome, and so on.

Related studies

Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy

NCT06968936 · Anemia, Iron Deficiencies, and more

Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.

NCT07236788 · Obesity, Anemia, and more

Kids With Iron Deficiency and Scoliosis

NCT06042699 · Adolescent Idiopathic Scoliosis, Neuromuscular Scoliosis, and more

Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women

NCT06909695 · Contraception, Iron Deficiencies

Active Not RecruitingNA

A Novel Iron-Based Supplement for Athletes Aged 14-17

NCT06338787 · Iron Deficiencies

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 11, 2024Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment3,000

Start dateJan 2024

Last updatedJan 11, 2024

Condition

Iron Deficiencies Calcified Aortic Valve

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 11, 2024Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions